The prostate is a small walnut-shaped gland present only in men that produces the seminal fluid that nourishes and protects sperm. At NURA, as part of the screening for Prostate Cancer we test for abnormal levels of Prostate Specific Antigen, a protein produced by the prostate.
Although the HPV vaccination reduces the possibility of developing cervical cancer
later in life, regular screening is a must as the vaccine does not protect against all types
of the virus.
It is the second most common cancer among Indian women. It can be easily prevented, as it
has a long pre-cancerous phase which can be detected if women screen themselves regularly.
Prostate cancer has four stages.
Stage I: Cancer is limited to the prostate and PSA levels are less than 10
Stage II: Cancer is limited to the prostate but PSA levels are between 10 and 20
Stage III: Cancer has spread beyond the outer layer of the prostate and may have spread to the seminal vesicles. The PSA can be any level.
Stage IV: Cancer has spread to seminal vesicles to nearby organs, lymph nodes and bones. PSA can be any level.
Prostate Specific Antigen (PSA) Test A blood test called a prostate specific antigen (PSA) test measures the level of PSA in the blood. PSA is a substance made by the prostate. The levels of PSA in the blood can be higher in men who have prostate cancer. The PSA level may also be elevated in other conditions that affect the prostate. As a rule, the higher the PSA level in the blood, the more likely a prostate problem is present. But many factors, such as age and race, can affect PSA levels. Some prostate glands make more PSA than others.